Migraine Aura: The Optometric Guide to Diagnosis, Differential Diagnosis, and Patient Management

A 17-year-old cousin calls you in a panic, her voice trembling.
"I can't see anything on the right side!" she exclaims. As an optometrist, your mind instantly shifts into diagnostic overdrive. Why is a healthy young woman experiencing a painless, sudden, unilateral visual field loss? You mentally run through the grim checklist: Central Retinal Artery Occlusion (CRAO)? A Branch Retinal Artery Occlusion (BRAO)? An ischemic optic neuropathy? A vitreous hemorrhage or retinal detachment? The possibilities are alarming.
Then, she adds, "And now, this intense, throbbing headache is starting on the left side of my head." The puzzle becomes more complex. You rush her to your clinic, your mind racing. A frantic, comprehensive ocular examination under the gaze of a vitreoretinal specialist reveals... nothing. No retinal ischemia, no hemorrhage, no detachment. The Fundus is pristine; the optic nerve heads are healthy. The visual field loss, as mysteriously as it appeared, begins to recede, leaving behind a residual headache and a profound sense of confusion. The diagnosis, which seemed so elusive in the moment of crisis, later becomes clear: it was Migraine with Aura.
If this scenario sounds familiar, you are not alone. Many patients experiencing the dramatic visual phenomena of a migraine aura present first to their optometrist, convinced the problem is solely with their eyes. Understanding migraine aura is therefore not just a neurological curiosity but a critical component of optometric practice, essential for providing accurate diagnosis, effective reassurance, and appropriate management.
Decoding the Complaint: The Clinical Spectrum of Migraine Aura
Migraine aura consists of fully reversible neurological symptoms lasting 5–60 minutes, typically preceding headache[1].

Figure 1Verywell / Brianna Gilmartin
Patients describe their experience in a variety of ways:
- Positive (or "irritative") phenomena: These are perceptions of something that isn't physically there. Patients report scintillations (shimmering, flickering lights), fortification spectra (jagged, zig-zag lines resembling the fortifications of a castle), or photopsia (flashes of light).

- Negative (or "deficit") phenomena: These represent a loss of function. This is what that cousin described—a scotoma (a blind spot in the visual field), hemianopia (loss of vision in one half of the visual field), or simply "blurry vision."

Epidemiology in India
A major community survey in Karnataka found a 1-year migraine prevalence of 25.2%[3].
Hospital-based data show 10–13% of migraine patients experience visual aur* [4][5].
Prevalence is higher among women and young adults [10].

ICHD-3 Diagnostic Criteria for Typical Aura
The classic visual aura often begins as a small paracentral scotoma that gradually expands, acquiring a shimmering, jagged border. It typically affects both eyes, though patients may perceive it as being in one eye if it dominates the temporal hemifield.
According to the International Classification of Headache Disorders (ICHD-3), for a diagnosis of "typical aura," the patient must have at least two attacks featuring fully reversible visual, sensory, or speech/language symptoms, with at least three of the following characteristics [7].
According to the International Classification of Headache Disorders (ICHD-3), for a diagnosis of "typical aura," the patient must have at least two attacks featuring fully reversible visual, sensory, or speech/language symptoms, with at least three of the following characteristics [7]
- One or more aura symptoms spread gradually over ≥5 minutes.
- Two or more aura symptoms occur in succession.
- Each individual aura symptom lasts 5-60 minutes.
The headache follows the aura with a free interval of less than 60 minutes.

Figure 2 Illustration by Malika Abbas
The Optometric Work-up: More Than a Refraction
When a patient presents with a history suggestive of aura, a targeted examination is crucial to rule out ocular and life-threatening mimics.

Figure 3 Illustration by Malika Abbas
- The Critical Case History: Key questions to ask include: "Did the visual disturbance start small and get bigger?" "Did it have shimmering or jagged edges?" "Did it affect one side of your vision in both eyes?" "How long did it last?" "Was it followed by a headache?"
- A dilated fundus examination is non-negotiable. This is essential to rule out retinal pathology such as a retinal detachment, vitreous hemorrhage, or, crucially, signs of retinal ischemia [2] that would point towards amaurosis fugax or a central/branch retinal artery occlusion. The latter would reveal retinal whitening (edema) and a cherry-red spot.
- Visual Fields: While the aura itself may have resolved, performing visual fields (confrontation, automated, or manual perimetry) can help document any residual deficits and provides a baseline. It also helps confirm the cortical, homonymous nature of the defect.
- Neuro-optometric Evaluation: A careful assessment of pupils, extraocular motility, and binocular vision is necessary to rule out other neurological conditions like a cranial nerve palsy that could indicate a brainstem or supranuclear issue.
The Critical Differential Diagnosis: When It's Not Migraine
This is where the optometrist's role as a primary care provider is vital. The ability to distinguish migraine aura from its sinister mimics can be sight and lifesaving.
- Amaurosis Fugax (Transient Monocular Vision Loss - TMVL): Often described as a "curtain coming down" over the vision of one eye. This is typically embolic in origin (e.g., from a carotid artery plaque) and is a negative phenomenon (vision loss only), lacking the positive phenomena of a typical aura. It is a major risk factor for stroke [2].
- Transient Ischemic Attack (TIA) / Stroke: A cerebral TIA affecting the occipital lobe can cause transient homonymous hemianopia. However, the symptoms are typically negative, maximal at onset, and may be associated with other neurological deficits like weakness, numbness, or aphasia. Any aura that lasts longer than 60 minutes, even if fully reversible, should be classified as a "prolonged aura" and raises concern; an aura lasting over 72 hours is a "migrainous infarction" and a medical emergency [7].
- Retinal Migraine: This is a rare and often misdiagnosed condition defined by the ICHD-3 as monocular visual disturbances (scotoma or blindness) lasting less than 60 minutes, associated with a migraine headache. It is a diagnosis of exclusion, and other causes of TMVL must be thoroughly ruled out [7].
- Other Ocular Conditions: Posterior Vitreous Detachment with persistent photopsia, or the acute phase of a optic neuropathy, can sometimes be confused, but their temporal profile and examination findings are different.
Pathophysiology for the Clinician: The Cortical Storm
So, what causes these dramatic symptoms without any visible ocular pathology? The answer lies in the brain. The widely accepted mechanism is Cortical Spreading Depression (CSD), a wave of neuronal and glial depolarization that spreads slowly (2-6 mm/min) across the cerebral cortex, followed by a period of suppressed neural activity [1].

Figure 4 Adapted from [1]
This wave was first hypothesized by Lashley in 1941 and later demonstrated in humans by the seminal fMRI study of Hadjikhani et al. [1]. They visually captured a wave of increased, followed by decreased, blood flow moving occipitally through the visual cortex during a spontaneous migraine aura, perfectly matching the patient's description of a spreading scotoma.
This wave of depolarization is the "storm" that creates the positive phenomena, while the subsequent suppression of brain activity causes the negative scotoma.
This CSD event is not isolated; it can activate the trigeminovascular system, leading to the release of inflammatory neuropeptides like Calcitonin Gene-Related Peptide (CGRP), which drives the dilation of cranial blood vessels and the perception of headache [8]. This explains the common temporal link between the visual aura and the ensuing pain.

Figure 5Migraine Pathophysiology Adapted from [11]
Management and Counselling: The Optometrist's Vital Role
Most patients with migraine aura do not require prescription medication managed by an optometrist, but our role in management is profound
- Reassurance and Education: For a patient terrified they are having a stroke or going blind, explaining the benign (though distressing) nature of aura is therapeutic in itself.
- Trigger Identification: Counsel patients on common migraine triggers: stress, lack of sleep, dehydration, certain foods (aged cheese, processed meats), caffeine, and hormonal fluctuations. Keeping a headache diary can be invaluable.
- Co-management and Referral: Know when to refer to a neurologist or primary care physician. Key indicators include new/worsening symptoms, atypical or prolonged aura, aura without headache in patients over 40 (to rule out TIA), or if the patient desires prophylactic or abortive pharmacological therapy.
- Optometric Interventions: This is a key area of our expertise. Many patients with migraine have co-existing visual stress (pattern glare) or subtle binocular vision anomalies. A thorough binocular vision workup can identify accommodative spasms or convergence insufficiency that may lower the migraine threshold. Managing these issues with vision therapy or prescribing precision tinted lenses (e.g., using the Intuitive Colorimeter system) has been shown to reduce headache frequency and visual discomfort in some patients [9]
Conclusion
Migraine aura is striking in appearance but generally benign in nature. Optometrists play a vital role in distinguishing cortical events from ocular emergencies, recognizing silent aura, navigating trigger patterns, and detecting stroke-associated warning signs. Through careful assessment and informed guidance, we help patients make sense of experiences that may otherwise feel alarming. In many ways, we serve as translators between the eye and the brain- explaining how a temporary ripple in neural activity can produce such vivid visual phenomena and restoring a sense of control where uncertainty once lived.
References
- Hadjikhani N, Sanchez Del Rio M, et al. Mechanisms of migraine aura revealed by functional MRI. PNAS. 2001.
- Friedman DI. The eye and headache. Continuum. 2014.
- Rao GN, et al. Prevalence of migraine in Karnataka, India. J Headache Pain. 2014.
- Sharma K, et al. Clinical profile of migraine with aura in North India. J Neurosci Rural Pract. 2021.
- Devulapally S, et al. Clinical patterns of migraine in Andhra Pradesh. Int J Adv Med. 2017.
- Shankar Kikkeri N, Nagalli S. Migraine With Aura. StatPearls Publishing; Updated 2024 Feb 29.
- Headache Classification Committee of the International Headache Society (ICHD?3). Cephalalgia. 2018.
- Goadsby PJ, et al. Pathophysiology of migraine. Physiol Rev. 2017.
- Evans BJW. Management of migraine. Optometry in Practice. 2007.
- European Society of Medicine. Migraine & Cognitive Impairment: Insights from India. 2023. DOI:10.18103/mra.v12i11.6011
- olner, E. A., Chen, S.-P., & Eikermann-Haerter, K. (2019). Current understanding of cortical structure and function in migraine. Cephalalgia, 39(13), 1683–1699. https://doi.org/10.1177/0333102419840643.

.jpg)
.jpg)
.jpg)
1.jpg)
.jpg)
.jpg)
.jpg)
.jpg)


1.jpg)



.jpg)
.jpg)



_(Instagram_Post).jpg)
.jpg)
_(1080_x_1080_px).jpg)


with_UP_Cabinet_Minister_Sh_Nand_Gopal_Gupta_at_OpticsFair_demonstrating_Refraction.jpg)
with_UP_Cabinet_Minister_Sh_Nand_Gopal_Gupta_at_OpticsFair_demonstrating_Refraction_(1).jpg)

.jpg)








.jpg)



.png)




